BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2560178)

  • 1. Pertussis toxin inhibits neuropeptide Y-induced feeding in rats.
    Chance WT; Sheriff S; Foley-Nelson T; Fischer JE; Balasubramaniam A
    Peptides; 1989; 10(6):1283-6. PubMed ID: 2560178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory and stimulatory effects of neuropeptide Y(17-36) on rat cardiac adenylate cyclase activity. Structure-function studies.
    Sheriff S; Balasubramaniam A
    J Biol Chem; 1992 Mar; 267(7):4680-5. PubMed ID: 1537851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line.
    Gordon EA; Kohout TA; Fishman PH
    J Neurochem; 1990 Aug; 55(2):506-13. PubMed ID: 2164571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism.
    Hackenthal E; Aktories K; Jakobs KH; Lang RE
    Am J Physiol; 1987 Mar; 252(3 Pt 2):F543-50. PubMed ID: 3548437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y inhibits beta-adrenergic agonist- and vasoactive intestinal peptide-induced cyclic AMP accumulation in rat pinealocytes through pertussis toxin-sensitive G protein.
    Harada Y; Okubo M; Yaga K; Kaneko T; Kaku K
    J Neurochem; 1992 Dec; 59(6):2178-83. PubMed ID: 1359017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory hypothalamic adenylate cyclase in anorectic tumor-bearing rats: implications for NPY-induced feeding.
    Chance WT; Balasubramaniam A; Borchers M; Fischer JE
    Brain Res; 1995 Sep; 691(1-2):180-4. PubMed ID: 8590051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiadrenergic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Millar BC; Piper HM; McDermott BJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):426-9. PubMed ID: 2854210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
    Zhu J; Li W; Toews ML; Hexum TD
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1479-86. PubMed ID: 1335068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Piper HM; Millar BC; McDermott BJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):333-7. PubMed ID: 2554154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y treatment and food deprivation increase cyclic AMP response element-binding in rat hypothalamus.
    Sheriff S; Chance WT; Fischer JE; Balasubramaniam A
    Mol Pharmacol; 1997 Apr; 51(4):597-604. PubMed ID: 9106624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y reduces macromolecule permeability of coronary endothelial monolayers.
    Noll T; Hempel A; Piper HM
    Am J Physiol; 1996 Nov; 271(5 Pt 2):H1878-83. PubMed ID: 8945904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.
    Galas L; Tonon MC; Beaujean D; Fredriksson R; Larhammar D; Lihrmann I; Jegou S; Fournier A; Chartrel N; Vaudry H
    Endocrinology; 2002 May; 143(5):1686-94. PubMed ID: 11956150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic administration of cAMP agonist/PKA activator inhibits both schedule feeding and NPY-induced feeding in rats.
    Sheriff S; Chance WT; Iqbal S; Rizvi TA; Xiao C; Kasckow JW; Balasubramaniam A
    Peptides; 2003 Feb; 24(2):245-54. PubMed ID: 12668209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells.
    Lobaugh LA; Blackshear PJ
    Am J Physiol; 1990 May; 258(5 Pt 1):C913-22. PubMed ID: 2159234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [D-TRP32]neuropeptide Y: a competitive antagonist of NPY in rat hypothalamus.
    Balasubramaniam A; Sheriff S; Johnson ME; Prabhakaran M; Huang Y; Fischer JE; Chance WT
    J Med Chem; 1994 Mar; 37(6):811-5. PubMed ID: 8145232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester-induced inhibition of the beta-adrenergic system in pulmonary endothelium: role of a pertussis toxin-sensitive protein.
    Newman KB; Michael JR; Feldman AM
    Am J Respir Cell Mol Biol; 1989 Dec; 1(6):517-23. PubMed ID: 2561591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of pertussis toxin on body temperature changes induced by neuropeptide Y and NPY2-36.
    Bouali SM; Fournier A; Jolicoeur FB
    Regul Pept; 1994 Dec; 54(2-3):367-72. PubMed ID: 7716271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of noradrenaline release by neuropeptide Y in mouse atria does not involve inhibition of adenylate cyclase or a pertussis toxin-susceptible G protein.
    Foucart S; Majewski H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):658-65. PubMed ID: 2482450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis toxin inhibits cAMP-induced desensitization of adenylate cyclase in Dictyostelium discoideum.
    Snaar-Jagalska BE; Van Haastert PJ
    Mol Cell Biochem; 1990 Feb; 92(2):177-89. PubMed ID: 2155382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of PT-treatment on ANP-mediated inhibition of adenylate cyclase and amylase release in rat parotid gland.
    Shimomura H; Nashida T; Imai A
    Mol Cell Biochem; 1994 Oct; 139(1):53-8. PubMed ID: 7531819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.